Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

Recombinant MMP-2 Monoclonal Antibody

Product Sizes
100 ul
£402.00
AN300112P-100UL
About this Product
SKU:
AN300112P
Additional Names:
TBE,CLG,Matrix Metalloproteinase,MMP,CLG4,CLG4A,MMP-2,MMP-II,MONA,TBE-1,MMP2,72 kDa Gelatinase,72 kDa Type IV Collagenase,Gelatinase A,Matrix Metalloproteinase-2,72kD type IV collagenase,72kDa gelatinase,72kDa type IV collagenase),CLG 4,CLG 4A,Collagenase Type 4 alpha,Collagenase type IV A,Gelatinase alpha,Gelatinase neutrophil,Matrix metallopeptidase 2 gelatinase A 72kDa gelatinase 72kDa type IV collagenase,Matrix Metalloproteinase 2,Matrix metalloproteinase 2 (gelatinase A,Matrix metalloproteinase II,MMP 2,MMP II,Neutrophil gelatinase,PEX,TBE 1
Application:
Western Blot
Buffer:
PBS
translate.label.attr.clone:
A1226
Clonality:
Recombinant Monoclonal
Concentration:
1 mg/ml
Extra Details:
Matrix Metalloproteinase-2 (MMP-2) is an enzyme that degrades components of the extracellular matrix and thus plays a pivotal role in cell migration during physiological and pathological processes. MMP-2 expression is dependent on extracellular matrix metalloproteinase inducer (EMMPRIN), Her2/neu, growth factors, cytokines, and hormones. Pro-MMP-2 activation needs MT1-MMP and TIMP-2 contribution. MMP-2 is changed in distribution and increased in amount in the ventral cochlear nucleus after unilateral cochlear ablation. A low level of MMP-2 is linked to a favorable prognosis in patients with a hormone receptor-negative tumor, usually associated with high risk. As a zymogen requiring proteolytic activation for catalytic activity, MMP-2 has been implicated broadly in the invasion and metastasis of many cancer model systems, including human breast cancer (HBC). Blocking MMP-2 secretion and activation during breast carcinoma development may decrease metastasis. The detection of active MMP-2 alone or the rate of pro-MMP-2 and active MMP-2 is considered a very sensitive indicator of cancer metastasis. Modulation of MMP-2 expression and activation through specific inhibitors and activators may thus provide a new mechanism for breast cancer treatment.
Host:
Rabbit
Immunogen:
Recombinant Human MMP-2 protein
Isotype:
IgG
Purification:
Protein A Purified
Reactivities:
Human
Shipping Conditions:
Blue Ice
Storage Conditions:
-20[o]C/-70[o]C Avoid freeze/thaw cycles., 2-8[o]C Avoid freeze/thaw cycles.
Supplier:
Elabscience
Type:
Antibody: Recombinant Antibodies